Olema Pharmaceuticals (OLMA)
10.68
0.00 (0.00%)
Upcoming Events
Latest Headlines
Lilly’s Cancer Bombshell Sparks Hunt for the Next Oncology Stock Set to Explode
June 1, 2026 9:05 AM - StreetInsider
Form 8-K Olema Pharmaceuticals, For: May 26
May 26, 2026 7:05 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)
May 22, 2026 6:54 AM - StreetInsider
Form 8-K Olema Pharmaceuticals, For: May 21
May 21, 2026 5:06 PM - SEC Filing
Olema Oncology reports early phase 1 data for cancer drug OP-3136
May 21, 2026 5:00 PM - StreetInsider
Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
May 21, 2026 5:00 PM - Globe NewsWire
Olema Oncology to Participate in Upcoming Investor Conferences
May 19, 2026 4:30 PM - Globe NewsWire
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P.
May 15, 2026 4:35 PM - SEC Filing
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: JANUS HENDERSON GROUP PLC
May 15, 2026 12:39 PM - SEC Filing
Citi Adjusts Catalyst Watch Names
May 13, 2026 4:09 PM - StreetInsider
Olema Pharmaceuticals (OLMA) PT Lowered to $35 at Guggenheim
May 13, 2026 6:38 AM - StreetInsider
Form 10-Q Olema Pharmaceuticals, For: Mar 31
May 12, 2026 7:11 AM - SEC Filing
Olema Pharmaceuticals, Inc. (OLMA) Tops Q1 EPS by 1c
May 12, 2026 7:09 AM - StreetInsider
Form 8-K Olema Pharmaceuticals, For: May 12
May 12, 2026 7:05 AM - SEC Filing
Olema Oncology Reports First Quarter 2026 Financial and Operating Results
May 12, 2026 7:00 AM - Globe NewsWire
Form 8-K Olema Pharmaceuticals, For: Apr 27
May 1, 2026 5:28 PM - SEC Filing
Form 4 Olema Pharmaceuticals, For: Apr 28 Filed by: Raman Prakash
April 29, 2026 7:54 PM - SEC Filing
Form 3 Olema Pharmaceuticals, For: Apr 28 Filed by: Raman Prakash
April 29, 2026 4:40 PM - SEC Filing
Form ARS Olema Pharmaceuticals, For: Dec 31
April 29, 2026 4:38 PM - SEC Filing
Form DEFA14A Olema Pharmaceuticals,
April 29, 2026 4:37 PM - SEC Filing
Form DEF 14A Olema Pharmaceuticals, For: Apr 29
April 29, 2026 4:36 PM - SEC Filing
Form 8-K Olema Pharmaceuticals, For: Apr 27
April 29, 2026 4:35 PM - SEC Filing
Olema Oncology appoints Prakash Raman to board of directors
April 29, 2026 4:01 PM - StreetInsider
Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors
April 29, 2026 4:01 PM - Globe NewsWire
Wolfe Research Starts Olema Pharmaceuticals (OLMA) at Peerperform
March 26, 2026 4:08 PM - StreetInsider
Form SCHEDULE 13G Olema Pharmaceuticals, Filed by: Invus Global Management, LLC
March 20, 2026 10:38 AM - SEC Filing
Jefferies Assumes Olema Pharmaceuticals (OLMA) at Buy
March 19, 2026 2:22 AM - StreetInsider
Olema Pharmaceuticals (OLMA) PT Raised to $58 at JPMorgan
March 18, 2026 8:22 AM - StreetInsider
Olema Pharmaceuticals (OLMA) PT Lowered to $27 at Goldman Sachs
March 18, 2026 6:58 AM - StreetInsider
Olema Pharmaceuticals (OLMA) PT Lowered to $38 at Guggenheim
March 17, 2026 6:55 AM - StreetInsider
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
March 16, 2026 4:04 PM - SEC Filing
Olema Pharmaceuticals (OLMA) PT Raised to $62 at Citi
March 16, 2026 3:02 PM - StreetInsider
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
March 16, 2026 12:44 PM - SEC Filing
Stifel on Olema Pharmaceuticals (OLMA): 'Investors Seeking Clarity on persevERA Miss'
March 16, 2026 10:14 AM - StreetInsider
Form S-8 Olema Pharmaceuticals,
March 16, 2026 7:19 AM - SEC Filing
Form 10-K Olema Pharmaceuticals, For: Dec 31
March 16, 2026 7:11 AM - SEC Filing
Form 8-K Olema Pharmaceuticals, For: Mar 16
March 16, 2026 7:05 AM - SEC Filing
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
March 11, 2026 4:20 PM - SEC Filing
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
March 10, 2026 12:28 PM - SEC Filing
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
March 9, 2026 3:16 PM - SEC Filing
Olema Pharmaceuticals (OLMA) PT Lowered to $38 at H.C. Wainwright
March 9, 2026 11:59 AM - StreetInsider
TD Cowen on Olema Pharmaceuticals (OLMA): 'Pala's Profile And Data Support Phase IIIs, Despite persevERA Disappointment'
March 9, 2026 10:32 AM - StreetInsider
Oppenheimer on Olema Pharmaceuticals (OLMA): "We think there’s more chapters to this story left to unfold"
March 9, 2026 9:15 AM - StreetInsider
Stifel Reiterates Buy Rating on Olema Pharmaceuticals (OLMA): Roche Ph3 outcome "not optimal for OLMA stock near term"
March 9, 2026 8:41 AM - StreetInsider
Stifel Suspects Olema Pharmaceuticals (OLMA) Holders 'may see today's sell-off as a buying opportunity'
March 9, 2026 7:34 AM - StreetInsider
Full Article List
